Carregant...

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Translating the recent success of chimeric antigen receptor (CAR) T cell therapy for hematological malignancies to solid tumors will necessitate overcoming several obstacles, including inefficient T cell tumor infiltration and insufficient functional persistence. Taking advantage of an orthotopic mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Transl Med
Autors principals: Adusumilli, Prasad S., Cherkassky, Leonid, Villena-Vargas, Jonathan, Colovos, Christos, Servais, Elliot, Plotkin, Jason, Jones, David R., Sadelain, Michel
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4373413/
https://ncbi.nlm.nih.gov/pubmed/25378643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3010162
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!